Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center.

Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab (2013) 2.06

Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol (2012) 1.42

Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. N Am J Med Sci (2015) 0.90

Prevalence of hypercalcemia among cancer patients in the United States. Cancer Med (2016) 0.89

Hypercalcemia of malignancy and new treatment options. Ther Clin Risk Manag (2015) 0.85

Correspondence (letter to the editor): Additional remarks. Dtsch Arztebl Int (2011) 0.84

Renal cell carcinoma presenting with paraneoplastic hypercalcemic coma: a case report and review of the literature. J Gen Intern Med (2007) 0.83

Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma. Int J Clin Oncol (2012) 0.80

Peripheral T-cell lymphoma with hypercalcemic crisis as a primary symptom accompanied by polymyositis: A case report and review of the literature. Oncol Lett (2014) 0.78

Calcitriol-induced hypercalcemia in a patient with granulomatous mycosis fungoides and end-stage renal disease. World J Nephrol (2013) 0.75

Quality and Outcomes of Treatment of Hypercalcemia of Malignancy. Cancer Invest (2015) 0.75

Hypercalcemia as Initial Presentation of Metastatic Adenocarcinoma of Gastric Origin: A Case Report and Review of the Literature. J Gastric Cancer (2016) 0.75

Update in palliative management of hormone refractory cancer of prostate. Indian J Urol (2007) 0.75

Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer (1993) 0.75

Autologous fascia lata for heart valve replacement. Thorax (1970) 3.75

Effect of pregnancy on prognosis for young women with breast cancer. Lancet (1994) 2.92

The chromosomal location and pleiotropic effects of mutations of the nirA+ gene of Escherichia coli K12: the essential role of nirA+ in nitrite reduction and in other anaerobic redox reactions. J Gen Microbiol (1978) 2.39

Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J (1973) 2.31

Reversible left-ventricular failure in angina pectoris. Lancet (1970) 2.27

Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment. Br Med J (1976) 2.23

Lead poisoning. Am J Med (1972) 1.90

Epidemic keratoconjunctivitis. Am J Public Health Nations Health (1970) 1.85

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Cancer (1993) 1.79

Phentolamine for vasodilator treatment of severe heart-failure. Lancet (1971) 1.71

Influence of nicardipine on the blood pressure at rest and on the pressor responses to cold, isometric exertion, and dynamic exercise in hypertensive patients. J Cardiovasc Pharmacol (1982) 1.67

Left ventricular angiography on exercise. A new method of assessing left ventricular function in ischaemic heart disease. Br Heart J (1976) 1.60

Ocular reaction to propranolol and resolution on continued treatment with a different beta-blocking drug. Br Med J (1975) 1.59

Effect of intravenous propranolol on the systemic circulatory response to sustained handgrip. Am J Cardiol (1966) 1.59

Effects of prenatal maternal estrogen on the male urogenital system. Obstet Gynecol (1980) 1.56

The circulatory effects of recumbent postural change in late pregnancy. Clin Sci (1967) 1.56

Computers in cardiovascular investigation. Br Heart J (1967) 1.53

Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease. Br Med J (Clin Res Ed) (1982) 1.50

Biochemical and genetic characterization of nirB mutants of Escherichia coli K 12 pleiotropically defective in nitrite and sulphite reduction. J Gen Microbiol (1980) 1.45

Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med (1979) 1.44

Expression and functional characterization of a soluble form of endothelial-leukocyte adhesion molecule 1. J Immunol (1991) 1.42

Heart valve replacement with reinforced aortic heterografts. Technique and results. J Thorac Cardiovasc Surg (1968) 1.38

Different effects of adrenergic beta-receptor blockade on heart rate response to mental stress, catecholamines, and exercise. Br Med J (1973) 1.36

Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am J Med (1980) 1.36

Surgery for abdominal metastases of cutaneous melanoma. World J Surg (2001) 1.33

Effect of dextran and ammonium sulphate on the reaction catalysed by a glucosyltransferase complex from Streptococcus mutans. J Gen Microbiol (1980) 1.33

Insulin secretion following myocardial infarction with particular respect to the pathogenesis of cardiogenic shock. Lancet (1969) 1.32

Comparison of adrenergic beta-blocking drugs in angina pectoris. Br Med J (1971) 1.32

The FEP (free erythrocyte porphyrins) test: a screening micromethod for lead poisoning. Pediatrics (1973) 1.31

Lead poisoning in New York City. Trans N Y Acad Sci (1971) 1.30

Pediatric trauma associated with all-terrain vehicles. J Pediatr (1986) 1.25

Advances in the management of infected urachal cysts. J Pediatr Surg (1986) 1.20

Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation. Eur J Immunol (1991) 1.20

Sarcoma metastatic to the brain: results of surgical treatment. Neurosurgery (1994) 1.19

Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension. Br Heart J (1974) 1.15

A study of cardiac output at rest throughout pregnancy. J Obstet Gynaecol Br Commonw (1967) 1.14

Systolic time intervals in measurement of inotropic response to drugs. Br Heart J (1981) 1.14

Phase I trial of Taxotere: five-day schedule. J Natl Cancer Inst (1992) 1.12

Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful? N Engl J Med (1982) 1.10

A long-term prevention study with oxprenolol in coronary heart disease. N Engl J Med (1982) 1.08

Anti-hypertensive dose-response effects of nicardipine in stable essential hypertension. Br J Clin Pharmacol (1985) 1.06

The significance of synchronous carcinoma and polyps in the colon and rectum. Cancer (1986) 1.06

Effects of adrenergic blockade on the pulmonary circulation in man. Br Heart J (1965) 1.05

Lack of a regulatory function for glutamine synthetase protein in the synthesis of glutamate dehydrogenase and nitrite reductase in Escherichia coli K12. J Gen Microbiol (1977) 1.04

Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (Mo) at presentation. Int J Radiat Oncol Biol Phys (1990) 1.04

Presentation of congenital diaphragmatic hernia past the neonatal period. Arch Surg (1986) 1.03

Insulin and glucose in the treatment of heart-failure. Lancet (1972) 1.00

Comparison of early side effects with amlodipine and nifedipine retard in hypertension. Cardiology (1992) 1.00

Insulin secretion in cardiogenic shock. Br Med J (1969) 0.99

Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. Lancet (1983) 0.95

Malaria transmission by leukocyte component therapy. JAMA (1971) 0.94

Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis. J Surg Res (1984) 0.93

Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease. Br Heart J (1982) 0.92

Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease. Br J Clin Pharmacol (1984) 0.92

Cooperative measles vaccine field trial. I. Clinical efficacy. Pediatrics (1966) 0.92

The nonoperative management of pediatric hepatic trauma. J Pediatr Surg (1983) 0.92

Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer (1993) 0.91

Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists. Br J Clin Pharmacol (1983) 0.91

Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer. Eur J Cancer Prev (2002) 0.91

Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction. Eur Heart J (1983) 0.91

Autonomic control of insulin secretion and the treatment of heart failure. Br Med J (1970) 0.90

Pharmacodynamic monitoring during acute intervention in ischaemic heart disease using a new echo-Doppler device. Br J Clin Pharmacol (1990) 0.89

Hepatic rupture caused by peliosis hepatis. J Pediatr Surg (2001) 0.89

Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol (1988) 0.89

Haemodynamic effects of beta-blockade in ischaemic heart failure. Lancet (1981) 0.88

Haemodynamic dose-response effects of intravenous nisoldipine in coronary artery disease. Br J Clin Pharmacol (1985) 0.87

Pleuroperitoneal shunts in the management of persistent chylothorax. Ann Thorac Surg (1989) 0.86

Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease. Int J Cancer (1988) 0.86

The incidence of herpes zoster in patients with Hodgkin's disease. An analysis of prognostic factors. Cancer (1985) 0.86

Localization of left ventricular ischaemia in angina pectoris by cineangiography during exercise. Br Heart J (1975) 0.86

Patient-controlled analgesia in pediatric surgery. J Pediatr Surg (1988) 0.86

Measurement of the cardiac output in man. Proc R Soc Med (1966) 0.86

Insulin secretion after open-heart surgery with particular respect to pathogenesis of low cardiac output state. Br Heart J (1971) 0.86

The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris. Eur Heart J (1984) 0.86

Haemodynamic effects of oxprenolol in hypertensive patients. Postgrad Med J (1970) 0.86

Surgical management of groin nodal metastases from primary melanoma of the lower extremity. Surg Gynecol Obstet (1992) 0.85

Insulin and the heart. J Mol Cell Cardiol (1971) 0.85

The circulatory effects of the Valsalva manoeuvre during anaesthesia and thoracotomy. Cardiovasc Res (1969) 0.85

Comparison of the pulmonary wedge pressure with the left ventricular end-diastolic pressure in man. Clin Sci (1968) 0.85

Cholecystokinin: a factor responsible for the enteral feedback control of pancreatic hypertrophyphy. Pancreas (1986) 0.84

Haemodynamic dose-response effects of i.v. verapamil in coronary artery disease. Herz (1984) 0.84

Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases. Cancer (1989) 0.84

Bretylium tosylate in prevention of cardiac dysrhythmias after myocardial infarction. Br Heart J (1970) 0.84

Beta-blocking drugs and myocardial function. J Cardiovasc Pharmacol (1986) 0.84

Insulin secretion in heart failure. Br Med J (1970) 0.84

Cystic sacrococcygeal teratoma: ultrasound diagnosis and perinatal management. J Ultrasound Med (1987) 0.83

Proceedings: Combined alpha and beta-receptor blockade in the treatment of severe hypertension. Scott Med J (1974) 0.83

Reoperation for recurrent metastatic brain tumors. J Neurosurg (1995) 0.83

Influence of sympatholytic drugs on the cardiovascular response to isometric exercise. Clin Sci (Lond) (1981) 0.83

Coronary insufficiency and beta-blockade. J Cardiovasc Pharmacol (1985) 0.83

Initiation and maintenance of beta-blockade with intravenous oxprenolol. Eur J Clin Pharmacol (1983) 0.83

Pharmacokinetic and pharmacodynamic studies with prazosin in chronic heart failure. J Cardiovasc Pharmacol (1981) 0.83

Haemodynamic dose-response effects of intravenous oxprenolol in coronary heart disease. J Cardiovasc Pharmacol (1981) 0.83

Haemodynamic dose-response actions of cicloprolol in left ventricular dysfunction due to ischaemic heart disease. Int J Cardiol (1987) 0.83

Clinical, electrocardiographic, and haemodynamic effects of digitalis (ouabain) in angina pectoris. Br Heart J (1972) 0.83

Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease. Eur Heart J (1982) 0.83

A study of the long-term efficacy and tolerability of oral nicardipine in hypertensive patients. Br J Clin Pharmacol (1985) 0.83

Hemodynamic effects of nifedipine during upright exercise in stable angina pectoris and either normal or severely impaired left ventricular function. Am J Cardiol (1984) 0.83